Following the sudden approval of the Ethereum Spot ETF last week, speculations continue to roll in on the potential performance of these funds ahead of their debut trading session. Most recently, renowned Bloomberg ETF analyst, James Seyffart has weighed in on the subject giving his thoughts on the possible level of investments the Ethereum spot ETFs could pull in relation to their Bitcoin-based equivalents.
Related Reading
ETH Spot ETF Limited By Ethereum’s Utility And Other Factors – Analyst
In an interview session on X on May 24 hosted by Bitwise Chief Investment Officer Matt Hougan, Seyffart stated that the Ether spot ETFs would likely experience a maximum of 25% of the demand seen by the Bitcoin spot ETFs.
Seyffart based his predictions on multiple elements starting with enormous differences in market caps between both assets. According to data from CoinMarket, Ethereum’s total market shares are valued at $449.25 billion which is roughly equal to 30% of BTC’s 1.35 trillion market cap.
Furthermore, the analyst also highlighted the large disparities in the difference between both ETFs and their base assets. According to Seyffart, there is a bigger gap between Ethereum as an ETF and as a cryptocurrency than Bitcoin as an ETF and as itself.
The ETF analyst believes that the ETH spot ETFs will limit investors from native ETF features such as staking, a prominent source of passive income, and other on-chain use cases in terms of DeFi, NFTs, DAOs, etc. Thus, certain investors might prefer to invest directly in the altcoin.
With all these factors in consideration, Seyffart predicts these novel investment funds will produce “big launches” but not at the level of the Bitcoin spot ETFs. He predicts the Ethereum Spot ETFs will record between 20-25% of investments in their Bitcoin-based peers once trading commences. Meanwhile, fellow Bloomberg analyst Eric Balchunas appears less optimistic with a projection of 15-20%.
Undoubtedly, the performance of the Ethereum spot ETFs will be influential on other crypto spot ETFs that may gain approval from the US Securities and Exchange Commission. Currently, the XRP ETF is tipped by many enthusiasts as the next debutant in the market but this is still subject to many factors, most especially regulatory clarity on the institutional sales of XRP.
Ethereum Price Overview
In other news, Ethereum is trading at $3,766 with a 0.51% gain in the last day. This slight positive performance underscores Ethereum’s form all week with a combined 20.47% gain recorded in the last seven days. Meanwhile, ETH’s daily trading volume is down by 51.27% and is valued at $10.03 billion.
Related Reading
Featured image from BitMEX, chart from Tradingview
Following the sudden approval of the Ethereum Spot ETF last week, speculations continue to roll in on the potential performance of these funds ahead of their debut trading session. Most recently, renowned Bloomberg ETF analyst, James Seyffart has weighed in on the subject giving his thoughts on the possible level of investments the Ethereum spot ETFs could pull in relation to their Bitcoin-based equivalents.
Related Reading
ETH Spot ETF Limited By Ethereum’s Utility And Other Factors – Analyst
In an interview session on X on May 24 hosted by Bitwise Chief Investment Officer Matt Hougan, Seyffart stated that the Ether spot ETFs would likely experience a maximum of 25% of the demand seen by the Bitcoin spot ETFs.
Seyffart based his predictions on multiple elements starting with enormous differences in market caps between both assets. According to data from CoinMarket, Ethereum’s total market shares are valued at $449.25 billion which is roughly equal to 30% of BTC’s 1.35 trillion market cap.
Furthermore, the analyst also highlighted the large disparities in the difference between both ETFs and their base assets. According to Seyffart, there is a bigger gap between Ethereum as an ETF and as a cryptocurrency than Bitcoin as an ETF and as itself.
The ETF analyst believes that the ETH spot ETFs will limit investors from native ETF features such as staking, a prominent source of passive income, and other on-chain use cases in terms of DeFi, NFTs, DAOs, etc. Thus, certain investors might prefer to invest directly in the altcoin.
With all these factors in consideration, Seyffart predicts these novel investment funds will produce “big launches” but not at the level of the Bitcoin spot ETFs. He predicts the Ethereum Spot ETFs will record between 20-25% of investments in their Bitcoin-based peers once trading commences. Meanwhile, fellow Bloomberg analyst Eric Balchunas appears less optimistic with a projection of 15-20%.
Undoubtedly, the performance of the Ethereum spot ETFs will be influential on other crypto spot ETFs that may gain approval from the US Securities and Exchange Commission. Currently, the XRP ETF is tipped by many enthusiasts as the next debutant in the market but this is still subject to many factors, most especially regulatory clarity on the institutional sales of XRP.
Ethereum Price Overview
In other news, Ethereum is trading at $3,766 with a 0.51% gain in the last day. This slight positive performance underscores Ethereum’s form all week with a combined 20.47% gain recorded in the last seven days. Meanwhile, ETH’s daily trading volume is down by 51.27% and is valued at $10.03 billion.
Related Reading
Featured image from BitMEX, chart from Tradingview
![Why Polygon [MATIC] is on track for a price rise](https://coininsights.com/wp-content/uploads/2024/05/polygon-balance-of-addresses-75x75.png)
where can i buy generic clomid how to get clomiphene price can you buy generic clomid without a prescription generic clomiphene pill can i buy clomid pill where to buy generic clomiphene tablets where can i get generic clomid no prescription
I am actually delighted to glitter at this blog posts which consists of tons of profitable facts, thanks representing providing such data.
More articles like this would pretence of the blogosphere richer.
zithromax 250mg generic – purchase metronidazole without prescription oral flagyl 400mg
buy rybelsus 14mg pill – periactin generic order periactin 4 mg sale
buy motilium pill – order cyclobenzaprine 15mg pill flexeril pills
order augmentin 625mg pill – at bio info how to get acillin without a prescription
purchase nexium online – anexamate nexium order
warfarin 5mg cheap – anticoagulant generic hyzaar
meloxicam canada – https://moboxsin.com/ buy mobic 7.5mg pills
buy generic prednisone online – aprep lson deltasone over the counter
buy ed meds – https://fastedtotake.com/ free ed pills
buy amoxil cheap – comba moxi amoxil sale
buy forcan no prescription – https://gpdifluca.com/# fluconazole 200mg us
purchase cenforce generic – cenforce rs brand cenforce 100mg